we all love

Company Profile

Haemogene, in collaboration with Health Service Laboratories (HSL) and University College London (UCL), pioneers the industry as the gold standard in advanced genomic solutions. With our cutting-edge technology and esteemed partnership, we offer a comprehensive array of Next-Generation Sequencing (NGS) testing services. Our mission is to deliver precise and personalized insights into genetic variations and molecular profiles, empowering healthcare professionals to make informed decisions for their patients.

Services Offered

1. *NGS Testing:* Our portfolio encompasses a wide range of NGS testing services, providing unparalleled depth and breadth of genomic analysis. Whether elucidating complex genetic disorders or exploring cancer genomics, we offer tailored solutions to meet diverse clinical and research needs.

2. *Full Myeloid Gene Panel:* Specializing in comprehensive myeloid gene panel testing, we ensure a thorough examination of genetic aberrations associated with hematological malignancies. Our advanced sequencing techniques guarantee robust coverage and accurate detection of relevant mutations, facilitating precise diagnosis and prognostication.

3. *Whole Genome Sequencing (WGS):* With Whole Genome Sequencing, we unlock the entirety of an individual’s genetic blueprint, offering unparalleled insights into inherited diseases, rare genetic variants, and complex genomic rearrangements. Our rigorous analytical pipelines adhere to the highest standards, ensuring reliable and actionable results.

4. *RNA Sequencing:* Leveraging state-of-the-art RNA sequencing technologies, we provide in-depth analysis of transcriptomes, unraveling gene expression patterns and molecular signatures underlying diverse biological processes and diseases.

5. *Molecular Panels:* Our customizable molecular panels are tailored to specific clinical indications, allowing targeted analysis of genes associated with inherited disorders, oncology, pharmacogenomics, and more.

6. *FISH (Fluorescence In Situ Hybridization) and CMA (Chromosomal Microarray Analysis):* Our FISH assays and CMA services provide valuable insights for cancer diagnosis, prognosis, and therapeutic decision-making, with exceptional sensitivity and specificity.

Integrated Reporting

At Haemogene, we understand the importance of actionable insights derived from complex genomic data. Our integrated reporting combines robust bioinformatics analysis with concise and clinically relevant interpretation, delivering clear and actionable findings to healthcare providers.

Lead Clinician

Professor Rajeev Gupta leads our clinical team, bringing unparalleled expertise and experience to our genomic testing services. As a renowned figure in the field, Professor Gupta ensures the highest standards of clinical excellence and innovation in every aspect of our operations.

Quality Assurance and Expertise

All testing is conducted in collaboration with HSL and UCL, ensuring the highest standards of quality assurance and expertise. Our partnership combines cutting-edge technology with renowned academic and clinical resources, guaranteeing the accuracy, reliability, and clinical relevance of our genomic testing services.

Introduction

In today’s fast-paced healthcare landscape, access to timely and accurate diagnostic reporting is crucial for informed decision-making and patient care. Remote Reporting Services, offered in partnership with Haemogene, represents a paradigm shift in diagnostic reporting, leveraging cutting-edge technology and expertise to deliver high-quality results regardless of geographical constraints. Our innovative business model combines onsite testing with remote interpretation and validation by qualified hematology consultants from Haemogene, ensuring unparalleled accuracy, efficiency, and accessibility in diagnostic reporting.

Key Features

Onsite Testing: Our clients benefit from onsite testing services conducted at their facilities, enabling rapid sample processing and analysis with minimal turnaround time. From blood tests to advanced genomic sequencing, our comprehensive testing capabilities cover a wide range of clinical indications, ensuring timely and reliable diagnostic results.

Remote Reporting: Following sample analysis, diagnostic reports are remotely interpreted and validated by qualified hematology consultants from Haemogene. Leveraging secure communication channels and advanced telemedicine platforms, our remote reporting services enable seamless collaboration between onsite healthcare providers and offsite experts, ensuring accurate interpretation and actionable insights.

Expert Consultation: Our team of experienced hematology consultants brings a wealth of expertise and clinical acumen to the diagnostic reporting process. From interpreting complex test results to providing clinical recommendations, our consultants work closely with onsite healthcare providers to ensure the highest standards of patient care and clinical decision-making.

Validation and Certification: All diagnostic reports undergo rigorous validation and certification by UCL (University College London) and HSL (Health Service Laboratories), renowned institutions at the forefront of medical research and healthcare innovation. This validation process ensures the accuracy, reliability, and clinical relevance of our diagnostic reports, providing confidence and peace of mind to healthcare providers and patients alike.

Benefits

Timely Reporting: Our remote reporting services enable rapid turnaround times for diagnostic reports, facilitating timely clinical decision-making and patient management.

Access to Expertise: By partnering with Haemogene and leveraging the expertise of qualified hematology consultants, healthcare providers gain access to specialized knowledge and insights, enhancing the quality of patient care.

Efficiency and Convenience: Our remote reporting model eliminates geographical barriers and streamlines the diagnostic reporting process, allowing healthcare providers to focus on patient care while ensuring accurate and reliable results.

Conclusion

Remote Reporting Services, offered in collaboration with Haemogene, represents a transformative approach to diagnostic reporting, combining onsite testing with remote interpretation and validation by expert hematology consultants. With a focus on accuracy, efficiency, and accessibility, our innovative business model revolutionizes the delivery of diagnostic services, empowering healthcare providers to make informed decisions and improve patient outcomes.

Haemogene offers specialized consultancy services in hematology, boasting a team of distinguished experts in the field, notably led by Professor Rajeev Gupta. Our consultancy encompasses comprehensive guidance on interpreting a wide array of hematology diagnostic results, incorporating advanced techniques such as Next-Generation Sequencing (NGS) testing. Our consultants combine clinical expertise with cutting-edge knowledge to provide actionable insights, allowing clients to understand the significance of test results within the broader clinical context. Whether it’s deciphering complex laboratory findings or offering tailored advice, Haemogene ensures precision and clarity in hematology consultancy.

Haemogene is committed to optimising laboratory utilisation and ensuring cost-effective healthcare delivery through our advocacy services. Our team collaborates closely with clinicians to provide expert guidance on selecting the most appropriate and impactful diagnostic tests to expedite accurate diagnoses while maximising resource efficiency.

In contexts where resources and funding are constrained, our advocacy efforts focus on identifying the most clinically relevant tests that yield actionable insights to benefit patients the most. By leveraging our deep understanding of hematology diagnostics and clinical expertise, we advise clinicians on selecting tests that not only offer diagnostic precision but also align with the patient’s clinical needs and the available resources.

Through this proactive approach, Haemogene aims to streamline laboratory testing processes, reduce unnecessary expenditures, and optimize patient outcomes. Our laboratory advocacy services underscore our commitment to delivering high-value care while navigating resource constraints effectively.

Haemogene extends its expertise through a comprehensive range of training services tailored for laboratory staff and clinicians alike. For laboratory personnel seeking to enhance their skills, we offer customised training programs where staff can visit Haemogene’s state-of-the-art laboratories (HSL labs) for hands-on training sessions. Additionally, our team can conduct on-site visits to distant laboratories, facilitating protocol reviews and optimization to ensure the highest standards of practice.

For clinicians eager to deepen their understanding of haematology, Haemogene organizes regular teaching seminars conducted by our esteemed consultants. These seminars provide a platform for clinicians to stay updated on the latest advancements in the field and gain insights into interpreting haematology diagnostic results effectively.

Moreover, as part of our commitment to continuous education, Haemogene offers clinicians the opportunity to spend time at HSL labs for immersive training experiences, allowing them to further refine their diagnostic and management skills under the guidance of our experts. With our comprehensive training services, Haemogene empowers both laboratory staff and clinicians to deliver exceptional care and excel in the field of haematology.